Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apixaban for PVT Prevention in Cirrhosis Post-Splenectomy
NCT05304455Completed
- Sponsor
- Subei People's Hospital
- Start
- Apr 2022
- Primary completion
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of apixaban in portal vein thrombosis (PVT), sponsored by Subei People's Hospital. Primary endpoint: Proportion of participants with Main and Intrahepatic Branches of Portal Vein Thrombosis at 6 months. Started Apr 2022; status: completed.
02
Drugs
apixaban
03
Conditions
portal vein thrombosis (PVT)
Beyond the preview
Go deeper on NCT05304455.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05304455.